Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

532 ARTÍCULOS , VIENDO DEL 286 AL 300

Preclinical Alzheimer Disease Drug Development: Early Considerations Based on Phase 3 Clinical Trials

Hung A, Schneider M, Lopez MH, McClellan M.

J Manag Care Spec Pharm. 2020 Jul;26(7):888-900. doi: 10.18553/jmcp.2020.26.7.888.

Popular three-dimensional models: Advantages for cancer, Alzheimer's and cardiovascular diseases

Ntamo Y, Samodien E, Muller CJF, Louw J, Chellan N.

Tissue Cell. 2020 Aug;65:101367. doi: 10.1016/j.tice.2020.101367. Epub 2020 Apr 17.

Editorial: Accelerating Preclinical Alzheimer's Clinical Trials through a Trial-Ready Cohort with Diverse Representation

Lee AKW, Correia S, Salloway SP.

J Prev Alzheimers Dis. 2020;7(4):204-205. doi: 10.14283/jpad.2020.43.

A meta-analysis of the effect of binge drinking on the oral microbiome and its relation to Alzheimer's disease

Yussof A, Yoon P, Krkljes C, Schweinberg S, Cottrell J, Chu T, Chang SL.

Sci Rep. 2020 Nov 16;10(1):19872. doi: 10.1038/s41598-020-76784-x.

Effects of a combined transcranial magnetic stimulation (TMS) and cognitive training intervention in patients with Alzheimer's disease

Sabbagh M, Sadowsky C, Tousi B, Agronin ME, Alva G, Armon C, Bernick C, Keegan AP, Karantzoulis S, Baror E, Ploznik M, Pascual-Leone A.

Alzheimers Dement. 2020 Apr;16(4):641-650. doi: 10.1016/j.jalz.2019.08.197. Epub 2020 Jan 16.

An Exploratory Phase IIa Study of the PPAR delta/gamma Agonist T3D-959 Assessing Metabolic and Cognitive Function in Subjects with Mild to Moderate Alzheimer's Disease

Chamberlain S, Gabriel H, Strittmatter W, Didsbury J.

J Alzheimers Dis. 2020;73(3):1085-1103. doi: 10.3233/JAD-190864.

Polysomnographic assessment of suvorexant in patients with probable Alzheimer's disease dementia and insomnia: a randomized trial

Herring WJ, Ceesay P, Snyder E, Bliwise D, Budd K, Hutzelmann J, Stevens J, Lines C, Michelson D.

Alzheimers Dement. 2020 Mar;16(3):541-551. doi: 10.1002/alz.12035. Epub 2020 Jan 15.

Danggui-Shaoyao-San for dementia: A PRISMA-compliant systematic review and meta-analysis

Kim Y, Cho SH.

Medicine (Baltimore). 2020 Jan;99(4):e18507. doi: 10.1097/MD.0000000000018507.

White Matter and Neuroprotection in Alzheimer's Dementia

Lorenzini L, Fernandez M, Baldassarro VA, Bighinati A, Giuliani A, Calzà L, Giardino L.

Molecules. 2020 Jan 23;25(3):503. doi: 10.3390/molecules25030503.

Safety and Efficacy of Donepezil 10 mg/day in Patients with Mild to Moderate Alzheimer's Disease

Jia J, Wei C, Chen W, Jia L, Zhou A, Wang F, Tang Y, Xu L.

J Alzheimers Dis. 2020;74(1):199-211. doi: 10.3233/JAD-190940.

Improvement of neuronal integrity with methylphenidate treatment for apathy in Alzheimer's disease

Padala PR, Padala KP, Samant RS, James GA.

Int Psychogeriatr. 2020 Apr;32(4):539-540. doi: 10.1017/S1041610220000095. Epub 2020 Feb 5.

Insulin resistance and impaired lipid metabolism as a potential link between diabetes and Alzheimer's disease

Kulas JA, Weigel TK, Ferris HA.

Drug Dev Res. 2020 Apr;81(2):194-205. doi: 10.1002/ddr.21643. Epub 2020 Feb 5.

Examination of the influence of cedar fragrance on cognitive function and behavioral and psychological symptoms of dementia in Alzheimer type dementia

Takahashi Y, Shindo S, Kanbayashi T, Takeshima M, Imanishi A, Mishima K.

Neuropsychopharmacol Rep. 2020 Mar;40(1):10-15. doi: 10.1002/npr2.12096. Epub 2020 Feb 9.

Donepezil plus memantine versus donepezil alone for treatment of concomitant Alzheimer's disease and chronic obstructive pulmonary disease: a retrospective observational study

Cao Y, Qian L, Yu W, Li T, Mao S, Han G.

J Int Med Res. 2020 Feb;48(2):300060520902895. doi: 10.1177/0300060520902895.

Safety and Neuroprotective Efficacy of Palm Oil and Tocotrienol-Rich Fraction from Palm Oil: A Systematic Review

Ismail M, Alsalahi A, Imam MU, Ooi J, Khaza'ai H, Aljaberi MA, Shamsudin MN, Idrus Z.

Nutrients. 2020 Feb 18;12(2):521. doi: 10.3390/nu12020521.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias